Related Experiment Video
Updated: May 27, 2026

10:10
A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
Published on: October 5, 2015
Predictive models for tuberculous pleural effusions in a high tuberculosis prevalence region
Ersin Demirer1, Andrew C Miller, Erdogan Kunter
1Department of Thoracic Medicine, GATA Haydarpaşa Training Hospital, Istanbul, Turkey.
Lung
|November 8, 2011
Summary
A new clinical score aids in diagnosing tuberculosis pleural effusion (TPE). The model uses age and pleural fluid adenosine deaminase enzyme levels for accurate TPE identification in high-prevalence areas.
Area of Science:
- Pulmonology
- Infectious Diseases
- Diagnostic Medicine
Background:
- Pleural effusions present diagnostic challenges, especially in tuberculosis-prevalent regions.
- Differentiating tuberculosis pleural effusion (TPE) from non-TB pleural effusion (NTPE) is crucial for effective treatment.
Purpose of the Study:
- To develop a simple and accurate clinical score for the differential diagnosis of TPE.
- To distinguish TPE from NTPE in patients with indeterminate pleural effusion etiology.
Main Methods:
- Prospective study of 248 Turkish patients (≥18 years) with pleural effusion of indeterminate cause.
- Logistic regression models were employed to identify predictors of TPE.
- A predictive model and summary score were developed and validated.
Main Results:
- Tuberculosis pleural effusion (TPE) was diagnosed in 63.3% of patients.
- A significant predictive model for TPE included age <47 years and pleural fluid adenosine deaminase enzyme (PADA) >35 U/l (OR: 7.46).
- The developed summary score demonstrated significant predictive value for TPE with a high area under the curve (AUC = 0.79).
Conclusions:
- An affordable and accurate clinical model combining age <47 years and PADA >35 U/l is proposed for diagnosing TPE.
- This model facilitates timely diagnosis in geographical areas with a high prevalence of tuberculosis.
Related Concept Videos
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pleural Effusion II: Symptoms and Management
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations: